NEW YORK (GenomeWeb) – Belgian diagnostics firm OncoDNA said today that it has signed an agreement under which its tumor profiling products and services will be offered in the Russian Federation by Genext.
Under the deal, Genext will market and distribute OncoDNA's OncoDeep solid tumor test; its OncoTrace and OncoSelect liquid biopsy tests; its OncoStrat&Go solid and liquid biopsy combination; and its OncoKDM data interpretation and reporting software.
Additional terms were not disclosed.
OncoDNA has signed a number of distribution agreements for its products in recent years including ones with CyberKnife Sigulda covering Latvia, Everything Genetic in the UK, BioHisto Maroc in Morocco, and Shchurko in Belarus.
In 2016, Genext became the exclusive distributor of Premaitha Health's Iona non-invasive prenatal screening test in Russia.